Your browser doesn't support javascript.
loading
Endoscopic ultrasound-guided choledochoduodenostomy using single-step lumen-apposing metal stents for primary drainage of malignant distal biliary obstruction (SCORPION-p): a prospective pilot study.
Fritzsche, Jeska A; Fockens, Paul; Besselink, Marc G; Busch, Olivier R; Daams, Freek; Montazeri, Nahid S M; Wilmink, Johanna W; Voermans, Rogier P; Van Wanrooij, Roy L J.
  • Fritzsche JA; Department of Gastroenterology and Hepatology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Fockens P; Amsterdam Gastroenterology Endocrinology Metabolism, Research Institute, Amsterdam, The Netherlands.
  • Besselink MG; Treatment and Quality of life, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Busch OR; Department of Gastroenterology and Hepatology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Daams F; Amsterdam Gastroenterology Endocrinology Metabolism, Research Institute, Amsterdam, The Netherlands.
  • Montazeri NSM; Treatment and Quality of life, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Wilmink JW; Department of Gastroenterology and Hepatology, Amsterdam UMC, location Vrije Universiteit, Amsterdam, The Netherlands.
  • Voermans RP; Amsterdam Gastroenterology Endocrinology Metabolism, Research Institute, Amsterdam, The Netherlands.
  • Van Wanrooij RLJ; Treatment and Quality of life, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Endoscopy ; 56(1): 47-52, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37473780
ABSTRACT

BACKGROUND:

This study aimed to assess the safety and feasibility of endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) using a lumen-apposing metal stent (LAMS) as a primary drainage strategy in patients with distal malignant biliary obstruction (MBO).

METHODS:

A prospective, single-center, pilot study was conducted in patients with pathology-confirmed MBO without gastric outlet obstruction. The primary outcome was technical success. Secondary outcomes included clinical success, adverse events (AEs), and reinterventions. The study was registered in the Netherlands Trial Registry (registry number NL9757).

RESULTS:

22 patients were enrolled (median age 69.5 years [interquartile range 64-75.3]). Technical success was achieved in 20/22 patients (91 %). AEs occurred in one patient, namely perforation following inadequate stent deployment (5 %), which was treated in the same procedure. Clinical success was achieved in 19/22 patients (86 %). Stent dysfunction was observed in 11/20 patients (55 %) after technically successful EUS-CDS two patients were treated conservatively and nine patients underwent reintervention(s). One patient died within ≤ 30 days due to fulminant disease progression.

CONCLUSIONS:

The results confirmed the safety and feasibility of EUS-CDS using LAMS as a primary drainage strategy. The high incidence of stent dysfunction should be improved before EUS-CDS with LAMS can be seen as a valid alternative to endoscopic retrograde cholangiopancreatography.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Coledocostomía / Drenaje / Colestasis Tipo de estudio: Risk_factors_studies Límite: Aged / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Coledocostomía / Drenaje / Colestasis Tipo de estudio: Risk_factors_studies Límite: Aged / Humans Idioma: En Año: 2024 Tipo del documento: Article